PRAX
Closed
Praxis Precision Medicines inc
43.17
+1.12 (+2.66%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 42.05
Day's Range: 40.93 - 43.88
Send
sign up or login to leave a comment!
When Written:
0.8659
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company that focuses on developing therapies for central nervous system (CNS) disorders. The company's lead product candidate, PRAX-114, is a small molecule that targets the GABA-A receptor system and is being developed for the treatment of major depressive disorder (MDD), neuropathic pain, and essential tremor. Praxis Precision Medicines also has a pipeline of other CNS-focused product candidates, including PRAX-944 for the treatment of epilepsy and other disorders, and PRAX-562 for the treatment of schizophrenia and related disorders. The company was founded in 2015 and is headquartered in Cambridge, Massachusetts.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








